Clicky

10x Genomics, Inc.(TXG)

Description: 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems. It offers chromium instruments, enzymes, reagents, microfluidic chips, and other consumable products, as well as software for analyzing biological systems. The company serves researchers in approximately 40 countries. Its customers include a range of academic, government, biopharmaceutical, biotechnology, and other institutions worldwide. 10X Genomics, Inc. was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. The company was incorporated in 2012 and is based in Pleasanton, California.


Keywords: Biotechnology Genomics Enzymes Consumable Products Biological Systems Life Science Technology

Home Page: www.10xgenomics.com

TXG Technical Analysis

6230 Stoneridge Mall Road
Pleasanton, CA 94588-3260
United States
Phone: 925 401 7300


Officers

Name Title
Dr. Serge Saxonov Ph.D. Co-Founder, CEO & Director
Dr. Benjamin J. Hindson Ph.D. Co-Founder, Pres, Chief Scientific Officer & Director
Mr. Justin J. McAnear Chief Financial Officer
Mr. Eric S. Whitaker Esq. Chief Legal Officer
Mr. Michael Schnall-Levin Founding Scientist & CTO
Ms. Cassie Corneau Mang. of Investor Relations and Strategic Fin.
Mr. Jonathan Schimmel VP of Global Support & Sales Operations
Ms. Rebecca Port Chief People Officer
Ms. Ruth De Backer Chief Bus. Officer
Mr. Jim Wilbur Ph.D. Chief Commercial Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 196.0784
Trailing PE: 0
Price-to-Book MRQ: 5.1581
Price-to-Sales TTM: 8.1308
IPO Date: 2019-09-12
Fiscal Year End: December
Full Time Employees: 1239
Back to stocks